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Abstract
Objective and methods: We have previously demonstrated that mechanical loading of cardiac fibroblasts leads to increased synthesis and
gene expression of the extracellular matrix protein collagen. We hypothesised that the upregulation of procollagen gene expression in cardiac
fibroblasts, in response to cyclic mechanical load, is mediated by one or more members of the MAP kinase family. To test this hypothesis, the
effect of mechanical load on the activation of extracellular signal-regulated kinase (ERK) 1/2, p46/54
JNK, and p38
MAPK was examined in rat
cardiac fibroblasts. Results: Peak phosphorylation of ERK 1/2, p38
MAPK kinases, and p46/54
JNK was observed following 10–20 min of
continuous cyclic mechanical load. Mechanical load significantly increased procollagen a1(I) mRNA levels up to twofold above static
controls after 24 h. This increase was completely abolished by the MEK 1/2 inhibitor U0126, with no effect on basal levels. In contrast,
SB203580, a specific inhibitor of p38
MAPK, enhanced both basal and stretch-stimulated levels of procollagen mRNA. Consistent with this
finding, selective activation of the p38
MAPK signalling pathway by expression of MKK6(Glu), a constitutive activator of p38
MAPK,
significantly reduced procollagen a1(I) promoter activity. SB203580-dependent increase in procollagen a1(I) was accompanied by ERK 1/2
activation, and inhibition of this pathway completely prevented SB203580-induced procollagen a1(I) expression. Conclusions: These results
suggest that mechanical load-induced procollagen a1(I) gene expression requires ERK 1/2 activation and that the p38
MAPK pathway
negatively regulates gene expression in cardiac fibroblasts. These pathways are likely to be key in events leading to matrix deposition during
heart growth and remodelling induced by mechanical load.
D 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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1. Introduction
The heart is continually subjected to mechanical forces
due to changes in blood volume and pressure. As the
physical properties of the heart are so important to its
function, so is the extracellular matrix fundamental in
maintaining the structure and function of the myocardium.
Fibrillar collagens are the most abundant components of the
extracellular matrix in the heart [1], and contribute signif-
icantly to the physical properties of tissues [2]. During
pathophysiological conditions such as hypertension, the
mechanical environment of the heart changes, resulting in
tissue remodelling. In vivo, this remodelling includes en-
largement of myocytes, proliferation of fibroblasts [3], and
increased procollagen synthesis [4–6]. In vitro, mechanical
loading induces cell hypertrophy and activation of a genetic
program (e.g., activation of c-jun and c-fos) similar to that
seen in the hypertrophic myocardium in vivo [7].I n
fibroblasts, we have previously shown that mechanical load
stimulates cardiac fibroblast procollagen gene expression
and synthesis [8,9]. Although the effects of mechanical load
on fibroblast function are becoming increasingly docu-
mented, the signal transduction pathways that mediate these
responses are still poorly understood.
Mechanical loading of myocytes stimulates a variety of
signal transduction pathways including the mitogen-activat-
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 ed protein kinase (MAPK) family member extracellular
signal-regulated kinase (ERK) 1/2, and its upstream activa-
tors MEK 1 and Raf-1 [10]. c-Jun NH2terminal kinase
(JNK) can also be activated by mechanical forces in cardiac
myocytes [11] and endothelial cells [12]. Activation of these
signalling pathways by mechanical load, as well as activa-
tion of protein kinase C and Rsk [13], have each been
implicated in signalling one or more components of the
hypertrophic phenotype. In cardiac fibroblasts, MacKenna
et al. [14] demonstrated that static mechanical load activates
ERK 1/2 and JNK1, although the downstream biological
events were not assessed. Components of the MAPK/ERK
1/2 cascade have been shown to contribute to the regulation
of procollagen gene transcription in transforming growth
factor-h1 (TGF-h1) stimulated 3T3 cells and activated rat
hepatic stellate cells [15,16]. However, the signalling path-
ways mediating the effects of mechanical load on collagen
gene expression remain as yet largely unknown. p38
MAPK is
activated by a variety of stimuli such as phenylephrine [17],
endothelin-1, oxidative stress [18], and hypoxia [19]. Acti-
vation of specific isoforms of p38
MAPK has been implicated
in the development of cardiomyocyte hypertrophy and
apoptosis [20], but has been little studied in the context of
collagen gene regulation.
To test whether strain-induced upregulation in procolla-
gen a1(I) gene expression is mediated via the MAP kinases,
we studied firstly the activation of these kinases by mechan-
ical load and then used pharmacological inhibitors of the
ERK 1/2 and p38
MAPK to determine their importance in
mediating this response. We report here that three members
of the MAP kinase family, ERK 1/2, p46/54
JNK,a n d
p38
MAPK, are activated by cyclic mechanical load in cardiac
fibroblasts. Inhibition of ERK 1/2 activity completely abro-
gated the mechanical load-induced procollagen a1(I) gene
expression, whereas inhibition of p38
MAPK activity poten-
tiated this process. These observations demonstrate a key
role for the ERK 1/2 and p38
MAPK pathways in the regula-
tion of extracellular matrix synthesis by mechanical load.
2. Materials and methods
2.1. Materials
All tissue culture reagents were purchased from GIBCO-
BRL (Paisley, UK). Anti-phospho-ERK 1/2, p38 antibodies,
and a nonradioactive kit to measure JNK activity were from
New England Biolabs (Hertfordshire, UK). Secondary IgG
conjugated to horseradish peroxidase was from DAKO
(Bucks, UK). The BCA protein assay reagent was from
Pierce and Warriner (Chester, UK). SB203580 was from
Calbiochem-Novabiochem (Nottingham, UK). The U0126
MEK inhibitor and the calcium phosphate ProFection Mam-
malian Transfection System were from Promega (Madison,
WI, USA). Chloramphenicol acetyl transferase (CAT) pro-
tein levels were measured by enzyme-linked immunosor-
bent assay (ELISA; Roche Diagnostics, Mannheim,
Germany). [a
32P]dCTP, the DNA Megaprime labelling kit,
and the enhanced chemiluminescence (ECL) system were
purchased from Amersham (Little Chalfont, Bucks, UK).
All other reagents were from Sigma (Dorset, UK).
2.2. Cell culture and mechanical loading
The investigation conforms with the guide for the Care
andUseofLaboratoryAnimalspublishedbytheUSNational
Institutes of Health (NIH Publication No. 85-23, revised
1996). Primary cultures of foetal rat cardiac fibroblasts were
prepared and grown to confluence on elastin-coated Flex I
platesk (Flexcell International, Chapel Hill, NC, USA) as
previously described [8]. Upon reaching visual confluence
(3–4 days), cells were incubated for 24 h in serum-free
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 50 Ag/ml ascorbic acid, 0.2 mM proline, 1
mg/mlbovine serumalbumin (BSA),and1Ag/mltransferrin.
The medium was then replaced with DMEM/10% foetal calf
serum (FCS) for 24 h and, subsequently, the cells were
subjected to mechanical load. Cells were cyclically loaded
for up to 24 h at a 1.5-Hz frequency and 20% maximum
elongation, using the Flexercell FX3000 apparatus. Rigid
control cultures on elastin-coated Flex I plates were grown in
parallel. Cells were used between passages 4 and 8.
2.3. Northern analysis of type I procollagen gene expression
Total RNA, pooled from the cell layers of six wells, was
extracted using 1 ml of TRIzol reagent as per manufac-
turers’ instructions (GIBCO-BRL). RNA loading buffer,
containing ethidium bromide (EtBr), was added to 5 Ago f
RNA, which was then fractionated on a 1% agarose gel.
Integrity of the RNA and uniformity of loading were
confirmed by quantitation of the EtBr-stained 28S ribosomal
RNA band, visualised and photographed under UV light.
RNA was transferred to a nylon membrane and hybridised
overnight with the a1(I) procollagen probe Hf677 [Ameri-
can Type Culture Collection (ATCC)], labelled with
[a
32P]dCTP. Two bands were obtained following hybrid-
isation, corresponding to 5.8 and 4.8 Kb of a1(I) procolla-
gen mRNA transcripts. The signal generated by both bands
was quantitated using a phosphorimager (Fuji) linked to
Advanced Image Data Analysis (AIDA) software (Fujifilm)
and normalised relative to the loading of total RNA in the
same sample analysing the ethidium bromide-stained 28S
ribosomal RNA band with the AIDA software.
2.4. Electrophoresis and immunoblotting
Confluent cultures of cells were lysed on ice with lysis
buffer [62.5 mM Tris–HCl (pH 6.8, 25 jC), 2% wt/vol
sodium dodecyl sulfate (SDS), 10% glycerol, 50 mM DTT,
and 0.1% bromophenol blue]. The cellular extracts, pooled
from two wells, and molecular mass standards were electro-
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 phoresed in 10% (wt/vol) SDS polyacrylamide gels and
transferred to nitrocellulose membranes. Even transfer and
equal loading were verified by Ponceau S staining of the
membranes. The blots were blocked with 5% nonfat dry
milk in Tris-buffered saline containing 0.05% (wt/vol)
Tween 20, and incubated with primary antibody overnight
at 4 jC. After washing, the membranes were incubated for 1
h with secondary antibody at room temperature. Immuno-
reactive bands were visualised by enhanced chemilumines-
cence and quantitated by densitometric scanning.
2.5. Immunoassay for p46/54
JNK activity
The procedure followed was that described in the instruc-
tions for the kit provided by New England Biolabs. Cells
were grown on elastin-coated Flex I plates as described
above. Briefly, cell lysis was accomplished by adding the
lysis buffer provided. Protein concentration was determined
by the BCA protein assay according to the manufacturer’s
instructions. Three hundred micrograms of protein was
incubated with 2 Ag of GST-c-Jun (1–89) fusion protein
bound to glutathione Sepharose beads to selectively precip-
itate JNKs. The kinase reaction was performed by the
addition of 100 AMA T Pf o r3 0m i na t3 0jC. c-Jun
phosphorylation was selectively measured using a phospho-
specific c-Jun antibody and immune complexes on nitrocel-
lulose membrane were visualised by enhanced chemilumi-
nescence as described previously for ERK 1/2 and p38
MAPK.
2.6. Expression vectors and reporter constructs
Expression vectors for MKK6 (Ala) (a dominant nega-
tive mutant of MKK6 in which lysine 82 is replaced with
alanine) and MKK6 (Glu) (a constitutively active mutant of
MKK6 in which serine 207 and threonine 211 are replaced
with glutamic acid) were kind gifts from Dr. R. Davis and
have been described elsewhere [21]. pColCAT3.6/1.6 (also
known as B16) was a gift from Drs. A. Lichtler and D.
Rowe (University of Connecticut Health Center, CT, USA).
This plasmid construct is identical to the B15 described by
B r e a u l te ta l .[22],e x c e p tt h a ta nEcoRV site in the
polylinker has been converted to a ClaI site. The construct
contains sequences between 3518 and +1594 (relative to
the transcription start site) of the rat COL1A1 gene, which
includes the upstream promoter region, the first exon (the
translational start site, ATG, has been converted to a NotI
site) and most of the first intron.
2.7. Transient transfections and promoter activity assays
Rat cardiac fibroblasts were transfected using the calcium
phosphate ProFection Mammalian Transfection System
Fig. 1. Effect of cyclic mechanical load on procollagen a1(I) mRNA levels
in foetal rat cardiac fibroblasts. Foetal rat cardiac fibroblasts were grown on
Flex
TM I plates as described in Materials and Methods. Cells were then
maintained rigid or subjected to continuous cyclic mechanical load for 24 h.
(A) Northern blot analysis of 5 Ag of total RNA using a cDNA probe for the
a1(I) procollagen. The 28S ethidium bromide-stained band is also shown.
(B) Densitometric analysis of procollagen a1(I) mRNA levels normalised to
the 28S ethidium bromide-stained band. Values are expressed as percentage
change from rigid control levels. Data were pooled from six independent
experiments and expressed as meanFS.E.M. *p<0.01 versus rigid control.
Fig. 2. Kinetics of activation of ERK 1/2, p38
MAPK, and p46/54
JNK in foetal
rat cardiac fibroblasts subjected to cyclic mechanical load. Cells were
grown as described in Fig. 1 and either maintained rigid or subjected to
mechanical load for the indicated times. Cell extracts were prepared as
described in Materials and Methods. Equal amounts of lysates were
separated by SDS polyacrylamide gel electrophoresis (PAGE) in 10% gels,
followed by immunoblotting with anti-phospho-ERK 1/2 (A), anti-
phospho-p38 (B). For JNK activity, cell lysates were incubated with c-
Jun fusion protein for 16 h at 4 jC. Immunoprecipitates were then collected
by centrifugation and incubated with 100 AM ATP. Twenty-five microliters
of the reaction mixture was subjected to SDS-PAGE and immunoblotting
with anti-phospho-c-Jun (C).
J. Papakrivopoulou et al. / Cardiovascular Research 61 (2004) 736–744 738
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 according to the manufacturer’s recommendations. Cells
were seeded onto 12-well plates 2 days before transfection.
Three hours after the addition of fresh serum containing
medium, transfections were performed in triplicate, with 0.5
Ag of DNA for pColCAT 3.6/1.6 and 0.5 Ag of DNA for
MKK6(Ala)/MKK6(Glu) or empty vector (pcDNA3). After
16 h, cells were rinsed twice with phosphate-buffered saline
(PBS) and incubated in serum-free DMEM containing
serum replacement 1, HEPES buffer, glutamine, ascorbic
acid, and proline, as described above. Twenty-four hours
later, transfected cells were switched to medium containing
2% foetal calf serum, and were incubated for a further 24 h.
Finally, plates were washed with PBS and lysed, and CAT
protein levels were measured by ELISA.
Fig. 3. Effects of U0126 and SB203580 inhibitors on mechanical load-induced procollagen a1(I) gene expression and phosphorylation of ERK 1/2, p46/54
JNK,
and p38
MAPK. Fibroblasts were maintained rigid or mechanically loaded for 24 h either in the absence or presence of the indicated concentrations of U0126 (A)
and SB203580 (C) added 30 min prior to the start of the mechanical loading. Total RNA (5 Ag) was subjected to Northern blot analysis using a cDNA probe for
the a1(I) procollagen. A representative autoradiogram is shown above, and the results of the densitometric analysis of a1(I) procollagen mRNA levels,
normalised to the 28S ethidium bromide-stained band, are shown below (percent change from rigid media control). Values are means of four independent
experiments FS.E.M. for U0126 and six independent experiments FS.E.M. for SB203580. *p<0.01 versus rigid control,
§p<0.01 versus loaded control.
Cells were mechanically loaded for 10 min (20 min for c-jun) in the presence or absence of the indicated concentrations of U0126 (B) or SB203580 (D). The
inhibitors were added 1 h prior to mechanical loading. Cell extracts were prepared and equal amounts were separated by SDS-PAGE, followed by
immunoblotting with anti-phospho ERK 1/2, anti-phospho-p38
MAPK, and anti-phospho-c-jun for p46/54
JNK, as described in Fig 2. Representative immunoblots
from at least three separate experiments are shown.
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 2.8. Pharmacological inhibitors
All inhibitors used were dissolved in dimethyl sulfoxide
(DMSO) to obtain a stock solution and stored at 20 jC.
The required concentrations of U0126 and SB203580 were
added to the cells 0.5–1 h prior to the application of
mechanical load. Vehicle (DMSO only) was added to
control cultures.
2.9. Statistical analysis
All numerical results are presented as meanFS.E.M.
The variation between data sets was tested with ANOVA,
and the significance between two data sets was tested with
unpaired t tests. Differences were considered significant
when p<0.05.
3. Results
3.1. Mechanical load upregulates procollagen a1(I) gene
expression by foetal rat cardiac fibroblasts
Confluent foetal rat cardiac fibroblasts were subjected to
continuous cyclic mechanical load and procollagen a1(I)
gene expression was assessed by Northern analysis (Fig. 1).
Procollagen a1(I) mRNA exists as two molecular weight
species, 4.8 and 5.8 kb, arising from two different poly-
adenylation sites (Fig. 1A). Fig. 1B shows that cyclic
mechanical loading resulted in a doubling in steady-state
procollagen a1(I) mRNA levels compared with static con-
trols. Similar results were seen in six separate experiments,
with steady-state procollagen a1(I) mRNA levels increased
between 65% and 140% in response to mechanical load.
3.2. The ERK 1/2 cascade positively regulates procollagen
a1(I) gene expression in cardiac fibroblasts
The effect of mechanical load on MAPKs activation in
foetal rat cardiac fibroblasts is shown in Fig. 2. ERK 1/2
phosphorylation was markedly enhanced after 10 min of
mechanical load and returned to baseline levels by 120 min.
Phosphorylation was shown to remain at basal levels after 6
h of continuous cyclic mechanical load (data not shown).
p38
MAPK phosphorylation was also increased after 10 min
and returned to basal levels by 60 min. p46/54
JNK activity
was detectable, as c-Jun phosphorylation, after 10 min of
loading, reached maximal levels after 20 min and returned
to basal levels by 2 h of continuous cyclic mechanical load.
Next we examined the role of the ERK 1/2 cascade in
mediating load-induced procollagen a1(I) gene expression
using the selective inhibitor of MEK activation, U0126 [23].
Fig. 3A shows that mechanical load resulted in an increase
in procollagen a1(I) mRNA levels of 67F10% (p<0.01),
which was markedly reduced at both concentrations of
U0126 examined: 2.5 and 5 AM. Fig. 3B shows that the
effect of U0126 in blocking load-induced ERK 1/2 activa-
tion occurs without any effects on the activation of p46/
54
JNK or p38
MAPK.
3.3. The p38
MAPK cascade negatively regulates procollagen
a1(I) gene expression in cardiac fibroblasts
Fig. 3C shows the effect of SB203580, a potent p38
MAPK
kinase inhibitor, on the load-induced increase in procollagen
type I gene expression. Treatment with this agent resulted in
an increase in procollagen mRNA levels above those
observed in both rigid control cells and mechanically loaded
cells. Basal levels of procollagen mRNA increased by
approximately 50–70% in treated cells and there was a
threefold increase in the stretch response in the presence of
the inhibitor. Examination of mechanical load-induced
p38
MAPK phosphorylation in the presence of SB203580
revealed that in foetal rat cardiac fibroblasts, this compound
inhibits phosphorylation of this kinase (Fig. 3D).
To further investigate the role of the p38
MAPK pathway in
the regulation of procollagen type I gene expression, we
used previously characterised expression constructs to mod-
ulate endogenous p38
MAPK activity. Procollagen a1(I) gene
expression was monitored by transfecting cardiac fibroblasts
with a fragment of the rat COL1A1 promoter fused to the
CAT reporter gene (pColCAT3.6/1.6). Expression of the
Fig. 4. Activation of the p38
MAPK pathway interferes with procollagen a1(I)
promoter activity. Cardiac fibroblasts were cotransfected with the pColCAT
3.6/1.6 reporter and expression vectors encoding MKK6(Ala), MKK6(Glu),
or empty pcDNA3 vector (vector). Following transfection, CAT protein
levels were determined as described in Materials and Methods and
normalised to the protein content of each extract. CAT protein levels in cells
transfected with empty vector were given an arbitrary value of 1. The
results are presented as meanFS.E.M. and are representative of three
independent experiments performed in triplicate.
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 constitutively activated MKK6(Glu) reduced CAT protein
levels at least threefold, when compared with CAT protein
levels in control cells transfected with the empty vector (Fig.
4). Expression of the dominant negative regulatory
MKK6(Ala) construct had no effect on CAT protein levels
compared with control cells. These results suggested that
activation of p38
MAPK by itself, via its upstream activator
MKK6, is sufficient to suppress procollagen type I gene
transcription.
3.4. SB203580-induced procollagen a1(I) gene expression is
mediated by the ERK 1/2 cascade
Since activation of the ERK 1/2 cascade was shown to
play an important role in the induction of procollagen type
I gene expression, and cross-talk between these two sig-
nalling pathways has recently been reported, we determined
whether the SB203580 compound has an effect on activa-
tion of ERK 1/2. We therefore performed an extended time
Fig. 5. SB203580-induced procollagen a1(I) gene expression is mediated by the ERK 1/2 pathway. (A and B) Kinetics of ERK 1/2 phosphorylation by
SB203580 in rigid and mechanically loaded cells. Cells were maintained rigid or mechanically loaded as described in Materials and Methods. At the start of the
experiment, cells were either left untreated or treated with SB203580 (5 AM), or U0126 (2.5 and 5 AM). After the indicated times, equal amounts of cell lysates
were separated by SDS-PAGE and immunoblotted with phospho-specific ERK 1/2 antibody. (C) Cardiac fibroblasts were grown to confluence in six-well
plates as described in Materials and Methods and were either untreated or treated with SB203580 (5 AM) for 24 h either in the absence or presence of indicated
concentrations of U0126 that was added 30 min prior to SB203580 addition. Total RNA (5 Ag) was subjected to Northern blot analysis using a cDNA probe for
the a1(I) procollagen. A representative autoradiogram is shown above, and the results of the densitometric analysis of a1(I) procollagen mRNA levels,
normalised to the 28S ethidium bromide-stained band, are shown below (percent change from media control). Results shown are representative of one
experiment.
J. Papakrivopoulou et al. / Cardiovascular Research 61 (2004) 736–744 741
b
y
 
g
u
e
s
t
 
o
n
 
O
c
t
o
b
e
r
 
3
1
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 course examining the effect of SB203580 on ERK 1/2
phosphorylation. SB203580 treatment resulted in a tran-
sient activation of ERK 1/2, which peaked at 20 min and
returned to near basal levels by 2 h (Fig. 5A). SB203580
also increased ERK 1/2 activation above control levels in
cells mechanically loaded over the same time period (Fig.
5B). To further elucidate the role of this pathway in
SB203580-induced procollagen a1(I) gene expression, we
used the U0126 inhibitor. U0126, at both concentrations
examined, inhibited SB203580-induced procollagen a1(I)
gene expression, (Fig. 5C), suggesting that the induction of
procollagen type I gene expression is mediated by the ERK
1/2 pathway.
4. Discussion
Mechanical stimuli have been shown to be potent
regulators of gene expression in the cardiovascular system.
Although studies have been carried out to determine the
mechano-signalling pathways that regulate hypertrophy in
isolated myocytes, few studies have examined the path-
ways that are important in the load response in cardiac
fibroblasts.
Cyclic mechanical load was shown to activate the three
major MAPK signalling pathways (ERK 1/2, p46/54
JNK,
and p38
MAPK) in foetal rat cardiac fibroblasts. Activation of
ERK 1/2 has previously been demonstrated in various cell
types in response to mechanical stimuli [12,24–27]. ERK 1/
2 and JNK1 have also been shown to be activated by static
stretch in adult cardiac fibroblasts [14]. This study is the
first to demonstrate p38
MAPK kinase activation by cyclic
mechanical load in cardiac fibroblasts.
As the three MAP kinases that we have examined have
distinct downstream targets, this simultaneous activation
may be a reflection of the multiple effects of mechanical
load on cellular function. In this study, we have focused on
the effect of mechanical load on procollagen gene expres-
sion. We demonstrate that, first, cyclic mechanical load
leads to an activation of ERK 1/2 in a time-dependent
manner (Fig. 2); and, second, U0126, a specific inhibitor
of MEK activity, inhibits both ERK 1/2 activation and
procollagen a1(I) gene expression induced by mechanical
load, without affecting phosphorylation levels of p46/54
JNK
and p38
MAPK (Fig. 3A and B).
The precise mechanism by which ERK 1/2 regulates
procollagen gene expression is presently unclear. We found
that activation of ERK 1/2 occurs within minutes of the
application of mechanical load, yet a significant upregula-
tion of procollagen a1(I) mRNA levels was not observed
until 24 h later. Since active ERK 1/2 translocates to the
nucleus, it may act directly on the procollagen gene.
Transcription factors of the Egr, Ets, and AP-1 families
have been suggested as possible downstream ERK 1/2
substrates [28–33]. The a1(I) procollagen gene contains
both AP-1 and Ets binding sites present in its 5V-UTR and
first intron [34–40], and therefore these sequences may
represent downstream targets of ERK 1/2. The delayed
increase in mRNA levels could then be due to a slow rate
of transcription of the procollagen gene. Another possibility
is that transcription factors activated by ERK 1/2 do not act
directly on the procollagen promoter, but on genes coding
for other downstream proteins necessary to cause the
increase in procollagen mRNA levels (e.g., transcription
factors, signalling molecules, or growth factors). These
mechanisms are currently under investigation.
We also investigated the role of the p38
MAPK pathway in
the regulation of procollagen gene expression. Classically,
the p38
MAPK cascade has been shown to be involved in
apoptosis and inflammatory reactions in response to cellular
stresses [41]. In the cardiovascular system, activation of the
p38
MAPK pathway has been linked to both hypertrophy and
apoptosis in cardiomyocytes [42]. Recently, a study by Chin
et al. [43] has implicated the p38
MAPK cascade in the
induction of procollagen type I gene expression in response
to TGF-h1 in mesangial cells.
The results presented in this study suggest that the
p38
MAPK signalling cascade exerts a negative regulatory
effect on procollagen type I expression. Using a specific
p38
MAPK inhibitor, SB203580 [44], we observed that inhi-
bition of this kinase had the opposite effect to inhibition of
ERK 1/2. Treatment with SB203580 resulted in superinduc-
tion of procollagen type I expression in both rigid and
mechanically loaded cells (Fig. 3B). Although the
SB203580 compound is commonly used as a specific
inhibitor of this kinase, reports have suggested that it may
act on other enzymes such as cyclooxygenase-1 and cyclo-
oxygenase-2 (COX-1/COX-2) and thromboxane A2 [45].
Cyclooxygenases are regulatory enzymes in the prostaglan-
din biosynthetic pathway, and prostaglandins of the E-type
have been shown to be potent inhibitors of procollagen
metabolism [46]. At this stage, we cannot rule out that the
observed effect of SB203580 on procollagen type I gene
expression in our system may be due to inhibition of COX-
1/COX-2. However, our observation that expression of
MKK6(Glu), a constitutive activator of p38
MAPK, signifi-
cantly suppressed procollagen type I promoter activity (Fig.
4) suggests that the effect of SB203580 on procollagen type
I gene expression is through its inhibition of the p38
MAPK
signalling cascade.
The exact mechanism(s) by which the p38
MAPK signal-
ling cascade may exert its effects on procollagen type I gene
expression remains to be elucidated. Our results demon-
strate cross-talk between the p38
MAPK and ERK 1/2 path-
ways, previously undescribed with relation to its role in the
regulation of procollagen a1(I) gene expression. Treatment
with SB203580 alone under static conditions (i.e., inhibition
of the p38
MAPK pathway) resulted in transient but delayed
(as compared to load) activation of the ERK 1/2 pathway.
Maximal activation was observed at 20 min, and was
sustained for up to 30 min following SB203580 treatment.
Examination of the effect of SB203580 on load-induced
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 ERK 1/2 activation, over the same time period, also
revealed increased ERK 1/2 activation observed up to 2
h of continuous loading (Fig. 5B). The existence of cross-
talk between the two pathways was further supported by the
observation that inhibition of ERK 1/2 phosphorylation by
U0126 attenuated SB203580-induced procollagen type I
expression. Taken together, our results suggest that the
p38
MAPK pathway represses activation of the ERK 1/2
pathway.
Cross-talk has been shown between different signalling
cascades and in a variety of cell types [47–50]. At this
point, the exact mechanism underlying this cross-talk is not
clear. Recent evidence, however, suggests that p38a
MAPK
can physically interact with ERK 1/2. This interaction is
enhanced upon phosphorylation of p38a
MAPK and is corre-
lated with inhibition of ERK 1/2 activity [51].T h e s e
observations provide a possible mechanism for the regula-
tion of procollagen type I gene expression by the p38
MAPK
pathway. Our results suggest that the p38
MAPK cascade
indirectly regulates procollagen type I gene expression
through its negative regulation of the ERK 1/2 cascade.
This latter effect may be due to a direct effect of a p38
MAPK
isoform on ERK 1/2 phosphorylation.
In summary, we have shown that ERK 1/2 plays an
essential role in the induction of procollagen a1(I) gene
transcription by mechanical load, thus establishing a link
between MAPK-mediated intracellular signalling and regu-
lation of procollagen gene expression. As all three MAPK
pathways appear to be activated by mechanical load, a
dynamic balance may be critical for determining/regulating
the final biological outcome(s). Understanding the cytoplas-
mic signalling involved in the regulation of such key
structural and disease related genes could lead to the
identification of potential therapeutic targets.
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